It has been reported that Merck Sharp & Dohme, a unit of Merck & Co, will be pledging guilty to one count of misbranding Vioxx with a penalty of $321.6 million criminal fine as well as $628.3 million in order to settle civil claims regarding the sale of Vioxx for unapproved uses along with fake statements about its cardiovascular safety.
135639
Merck Sharp & Dohme pledges guilty
135035
Mabey & Johnson pleads guilty
141704
GlaxoSmithKline agrees to $750 million settlement
117000
Report warns against combination painkillers
42192
Woman charged with forging prescription
139139
Health region responds to charges
78247
Powder mailed to Wall Street Journal, Harvard Law
67567
Firm fined for safety failings
154298
Online sales of fake drugs targeted
137813
Jury orders Pfizer to pay $US38 million
106023
Columbia dentist pleads guilty to writing fraudulent prescriptions
158905
Toyota may face $16.4 million fine
27381
$1 verdict against police costs nearly $600,000 in legal fees
166275
Merck to buy Schering-Plough for $41.1 billion
108258
Bonds found guilty
118142
Company fined after worker exposed to hazardous chemical
146605
Company to pay $7 million to resolve allegations